1.Bilateral Traumatic Anterior Dislocation of the Hips: A Case Report
Byung Ill LEE ; Soo Kyoon RAH ; Chang Wuk CHOI ; Hyung Deuk KIM
The Journal of the Korean Orthopaedic Association 1985;20(2):358-362
Even though the incidence of traumatic anterior dislocation of the hip is approximately 15% of all traumatic dislocation, the incidence of bilateral traumatic anterior dislocation is extremely rare. In a review of literature, the authors could find only one case report of bilateral traumatic anterior dislocation of the hip and no case in Korea. The mechanism of traumatic anterior dislocation of the hip is forced abduction. This paper is a case report of a traumatic bilateral anterior dislocation of the hips in a 36 year old labor who injured by fall down from about 5 meter in height. The case was treated by means of closed reduction, traction and physical therapy. Follow up study was performed for one year and obtained good result.
Dislocations
;
Follow-Up Studies
;
Hip Dislocation
;
Hip
;
Incidence
;
Korea
;
Traction
2.Lipids in Ginseng (Panax ginseng) and Their Analysis
So Hyun KIM ; Seok Young KIM ; Hyung Kyoon CHOI
Natural Product Sciences 2018;24(1):1-12
Ginseng (Panax ginseng) is recognized as one of the most valuable medicinal herbs in Asia and it contains diverse phytochemicals that contribute to its pharmacological effects. Although lipids represent a major component of ginseng, ginseng lipids are still far from being fully explored. This review is focused on ginseng lipid components and methodologies of their analysis. The ginseng lipid compounds were categorized according to the structural features of each lipid class. This basic information on ginseng lipid components and the analysis methods will be applicable to authentification or quality control of ginseng products, and development of lipid-based pharmaceuticals and nutraceuticals from ginseng.
Asia
;
Dietary Supplements
;
Panax
;
Phytochemicals
;
Plants, Medicinal
;
Quality Control
3.A case of tuberculosis of the stomach with bronchoesophageal fistula.
Jong Young LEE ; Chan Keun PARK ; Yong Ah BAEK ; Oung Seung CHOI ; Hyung Gil KIM ; Dong Kyoon CHUNG ; Kwang Je OH ; Cho Young CHOI ; Soo Nam LEE
Tuberculosis and Respiratory Diseases 1991;38(2):172-178
No abstract available.
Fistula*
;
Stomach*
;
Tuberculosis*
4.Gemcitabine as second-line chemotherapy in patients with recurrent epithelial ovarian cancer: Review of four cases.
Yong Joo PARK ; Chul Min LEE ; Hyung Joo SEO ; Hye Joo LEE ; Jaung Sun KIM ; Ji Kyung KO ; Yong Kyoon CHO ; Hoon CHOI ; Bok Rin KIM ; Hong Kyoon LEE
Korean Journal of Obstetrics and Gynecology 2004;47(11):2209-2212
Adjuvant multiagent chemotherapy with platinum and paclitaxel after optimal cytoreductive surgery decisively improved survival rates of patients with epithelial ovarian carcinoma. However, more than two- thirds of patients with advanced disease will encounter tumor progression, underlining the need for effective second-line strategies. Continued efforts to discover new active agents for the treatment of patients with ovarian carcinoma had identified gemcitabine. Four patients with epithelial ovarian carcinoma, who were treated in Inje University Sanggye Paik Hospital and recurred thereafter received gemcitabine 1,000 mg/m2 as a 30 min intravenous infusion on days 1, 8, and 15, which was repeated every 28 days. The disease progressed in two patients, while one showed stable disease and another reached complete response. One patient expired of disease two months after the completion of therapy. Grade 3 leukopenia was successfully managed using G-CSF. Regrowth of hair lost during previous chemotherapy occurred in all subjects. We report four cases of advanced recurrent ovarian carcinoma which were treated with gemcitabine.
Drug Therapy*
;
Granulocyte Colony-Stimulating Factor
;
Hair
;
Humans
;
Infusions, Intravenous
;
Leukopenia
;
Ovarian Neoplasms*
;
Paclitaxel
;
Platinum
;
Survival Rate
5.Second-line Chemotherapy with Paclitaxel and Carboplatin for Patients with Recurrent Ovarian Carcinoma.
Hyung Joo SEO ; Chul Min LEE ; Jaung Sun KIM ; Hye Joo LEE ; Yong Joo PARK ; Yong Kyoon CHO ; Hoon CHOI ; Bok Rin KIM ; Hong Kyoon LEE
Korean Journal of Obstetrics and Gynecology 2004;47(10):1915-1920
OBJECTIVE: This study is to investigate the efficacy and toxicity of paclitaxel plus carboplatin used as a salvage therapy. METHODS: Between June 2000 and November 2003, 10 patients aged 43-74 (median 55.0) with recurrent ovarian carcinoma were given combination chemotherapy including paclitaxel and carboplatin. The subjects received initial chemotherapy with paclitaxel plus cisplatin/carboplatin. On recurrence, paclitaxel was administered intravenously at a dose of 175 mg/m2 with carboplatin by AUC 5 every 3 weeks. The median treatment cycle was 10 cycles (range, 1 to 15 cycles). Recurrence of ovarian carcinoma was determined by elevation of serum CA-125, or radiologic imaging. Responses and toxicities were evaluated according to Gynecologic Oncology Group criteria and Common Terminology Criteria for Adverse Events from NCI (National Cancer Institute). RESULTS: The overall clinical response rate was 60.0% (6/10). Better response was observed in patients who were sensitive with initial chemotherapy. Anemia was the most frequent complication. CONCLUSION: Paclitaxel and carboplatin has been shown to be a feasible agent in patients with recurrent ovarian cancer.
Anemia
;
Area Under Curve
;
Carboplatin*
;
Drug Therapy*
;
Drug Therapy, Combination
;
Humans
;
Ovarian Neoplasms
;
Paclitaxel*
;
Recurrence
;
Salvage Therapy
6.Cold lesions in Tc-MDP bone scans of patients with skeleted metastases.
Chang Woon CHOI ; Hyung In YANG ; Sang Kyoon BAE ; Dong Soo LEE ; In SON ; Joon Ki JEONG ; Myung Chul LEE ; Chang Soon KOH
Korean Journal of Nuclear Medicine 1993;27(1):98-103
No abstract available.
Humans
;
Neoplasm Metastasis*
7.Application of Metabolomics to Quality Control of Natural Product Derived Medicines.
Kyung Min LEE ; Jun Yeong JEON ; Byeong Ju LEE ; Hwanhui LEE ; Hyung Kyoon CHOI
Biomolecules & Therapeutics 2017;25(6):559-568
Metabolomics has been used as a powerful tool for the analysis and quality assessment of the natural product (NP)-derived medicines. It is increasingly being used in the quality control and standardization of NP-derived medicines because they are composed of hundreds of natural compounds. The most common techniques that are used in metabolomics consist of NMR, GC-MS, and LC-MS in combination with multivariate statistical analyses including principal components analysis (PCA) and partial least squares-discriminant analysis (PLS-DA). Currently, the quality control of the NP-derived medicines is usually conducted using HPLC and is specified by one or two indicators. To create a superior quality control framework and avoid adulterated drugs, it is necessary to be able to determine and establish standards based on multiple ingredients using metabolic profiling and fingerprinting. Therefore, the application of various analytical tools in the quality control of NP-derived medicines forms the major part of this review. Veregen® (Medigene AG, Planegg/Martinsried, Germany), which is the first botanical prescription drug approved by US Food and Drug Administration, is reviewed as an example that will hopefully provide future directions and perspectives on metabolomics technologies available for the quality control of NP-derived medicines.
Chromatography, High Pressure Liquid
;
Dermatoglyphics
;
Metabolomics*
;
Prescriptions
;
Quality Control*
;
United States Food and Drug Administration
8.Characterization of Glycosyl Inositol Phosphoceramides from Panax ginseng using Nanospray Tandem Mass Spectrometry
So-Hyun KIM ; Ye-Been LEE ; Yoonho JEONG ; Jae-Yeon CHO ; Hyung-Kyoon CHOI
Natural Product Sciences 2024;30(2):103-116
Korean ginseng (Panax ginseng C. A. Meyer) is one of the most popular medicinal herbs in the world. This plant is known to have many health benefits and contain a wide variety of bioactive components. However, the knowledge on its lipid compound is still far from being fully explored. Although glycosyl inositol phosphoceramides (GIPCs) are the main sphingolipids in plant tissues, GIPCs of P. ginseng are unknown. The present study employed nanoESI-MS n , which generated characteristic fragmentation pattern that were used for the structural identification of P. ginseng GIPCs. In addition to detecting a typical mass fragmentation pattern for GIPC in positive ion mode, novel fragmentation correlating with cleavage of the last carbohydrate and fatty acyl chain of the ceramide moiety was identified. In total, 42 GIPC species were detected in P. ginseng. The major P. ginseng GIPC structure was hexose (R 1 )-hexuronic acid-inositol phosphoceramide, with three types of R 1 (amine, N-acetylamine, or hydroxyl). The most intense peak was found at m/z 1136.3 ([M+H] + ion), corresponding to a GIPC (d18:0/h16:0, R 1 = OH). Only three GIPC subtypes showed significantly different levels in five- and six-year-old P. ginseng tap roots.
9.Effects of a Rubus coreanus Miquel supplement on plasma antioxidant capacity in healthy Korean men.
Ji Eun LEE ; Eunkyo PARK ; Jung eun LEE ; Joong Hyuck AUH ; Hyung Kyoon CHOI ; Jaehwi LEE ; SooMuk CHO ; Jung Hyun KIM
Nutrition Research and Practice 2011;5(5):429-434
Korean raspberry, Rubus coreanus Miquel (RCM), contains high concentrations of phenolic compounds, which prevent oxidative stress. To determine the effect of RCM on antioxidant capacity in humans, we assessed in vivo lipid oxidation and antioxidant enzyme activities from plasma in 15 healthy men. The subjects ingested 30 g of freeze-dried RCM daily for 4 weeks. Blood was taken at baseline and at the end of the study to determine blood lipid profiles, fasting plasma glucose, liver function, lipid peroxidation, and antioxidant enzyme activities. RCM supplementation had no effect on blood lipid or fasting plasma glucose concentrations but decreased alkaline phosphatase activity. RCM supplementation increased glutathione peroxidase activities (P < 0.05) but had no effect on lipid peroxidation. These results suggest that short-term RCM supplementation may offer health benefits by enhancing antioxidant capacity in a healthy population.
Alkaline Phosphatase
;
Fasting
;
Glucose
;
Glutathione Peroxidase
;
Humans
;
Insurance Benefits
;
Lipid Peroxidation
;
Liver
;
Male
;
Oxidative Stress
;
Phenol
;
Plasma
10.Reversible Infertility Associated with Testosterone Therapy for Symptomatic Hypogonadism in Infertile Couple.
Jeong Kyoon BANG ; Jung Jin LIM ; Jin CHOI ; Hyung Jae WON ; Tae Ki YOON ; Jae Yup HONG ; Dong Soo PARK ; Seung Hun SONG
Yonsei Medical Journal 2013;54(3):702-706
PURPOSE: Androgen replacement therapy has been shown to be safe and effective for most patients with testosterone deficiency. Male partners of infertile couples often report significantly poorer sexual activity and complain androgen deficiency symptoms. We report herein an adverse effect on fertility caused by misusage of androgen replacement therapy in infertile men with hypogonadal symptoms. MATERIALS AND METHODS: The study population consisted of 8 male patients referred from a local clinic for azoospermia or severe oligozoospermia between January 2008 and July 2011. After detailed evaluation at our andrology clinic, all patients were diagnosed with iatrogenic hypogonadism associated with external androgen replacement. We evaluated changes in semen parameters and serum hormone level, and fertility status. RESULTS: All patients had received multiple testosterone undecanoate (NebidoR) injections at local clinic due to androgen deficiency symptoms combined with lower serum testosterone level. The median duration of androgen replacement therapy prior to the development of azoospermia was 8 months (range: 4-12 months). After withdrawal of androgen therapy, sperm concentration and serum follicle-stimulating hormone level returned to normal range at a median 8.5 months (range: 7-10 months). CONCLUSION: Misusage of external androgen replacement therapy in infertile men with poor sexual function can cause temporary spermatogenic dysfunction, thus aggravating infertility.
Adult
;
Androgens/administration & dosage/adverse effects/*therapeutic use
;
Azoospermia/*drug therapy
;
Erectile Dysfunction/drug therapy
;
Humans
;
Hypogonadism/*drug therapy
;
Infertility, Male/*chemically induced/drug therapy
;
Male
;
Oligospermia/*drug therapy
;
Testosterone/administration & dosage/adverse effects/*analogs & derivatives/therapeutic use